However, MMP9, NR4A2 and notably NFKBIA, which encodes the inhibitor of the pathway IkBα but serves as a reliable indicator of NF-kB signaling, exhibited statistically significant lower expression in CLL samples (Figure 1A). This evidence concerns the gene NFKBIA and B-cell chronic lymphocytic leukemia.